Mavacamten Impurity 26 | CAS 618-36-0 - Request Quote
Mavacamten Impurity 26
| SZ CAT No: | SZ-M132032 |
| CAS No | 618-36-0 |
| Mol.F. | C8H11N |
| Mol.Wt. | 121.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
CHNS Ratio (%) :
Usage Note:
Mavacamten Impurity 26 is chemically 1-Phenylethan-1-amine. Mavacamten Impurity 26 is supplied with detailed characterization data compliant with regulatory guideline. Mavacamten Impurity 26 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Mavacamten.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 618-36-0
Purchase 618-36-0
Order 618-36-0
Enquire 618-36-0
price of 618-36-0
618-36-0 Supplier
618-36-0 Manufacturer
618-36-0 Exporter
buy high quality Mavacamten Impurity 26
Purchase Mavacamten Impurity 26
Mavacamten Impurity 26 suppliers
Mavacamten Impurity 26 manufacturers
Mavacamten Impurity 26 price
Order Mavacamten Impurity 26
Enquire Mavacamten Impurity 26
Mavacamten Impurity 26 cost
Mavacamten Impurity 26 Supplier
Mavacamten Impurity 26 Distributor
Mavacamten Impurity 26 for Method Validation
Mavacamten Reference Standard
Mavacamten Impurity 26 for ANDA Filing
Mavacamten Impurity 26 for Forced Degradation Studies
Mavacamten Impurity 26 Identification Standards
Mavacamten Impurity 26 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.